Whitehawk Therapeutics (3350) Q2 2026 Earnings Report
DE:3350 Q2 2026 EPS Results
- Actual EPS
- -EUR 0.18
- Consensus EPS
- -EUR 0.27
- Beat/Miss
- Beat by +EUR 0.09
- One Year Ago EPS
- -EUR 0.68
DE:3350 Q2 2026 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- -EUR 313.39K
- Beat/Miss
- Beat by +EUR 313.39K
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/06/2026
- Time
- Before Open
- Conference Call
- Thursday, August 6, 2026
DE:3350 Upcoming Earnings
Whitehawk Therapeutics's next earnings date is estimated for November 11, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:3350 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 11, 2026 | 2026 (Q3) | -0.19- | -0.23 | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | -0.27-0.18 | -0.68 | 73.68% (+0.50) | |
| May 07, 2026 | 2026 (Q1) | -0.32-0.29 | 1.64 | -117.49% (-1.93) | |
| Mar 12, 2026 | 2025 (Q4) | -0.43-0.30 | -0.6 | 49.25% (+0.30) | |
| Nov 06, 2025 | 2025 (Q3) | 0.06-0.23 | -0.41 | 43.48% (+0.18) | |
| Aug 07, 2025 | 2025 (Q2) | 0.74-0.68 | -0.48 | -40.74% (-0.20) | |
| May 08, 2025 | 2025 (Q1) | -0.411.64 | -0.61 | 369.12% (+2.25) | |
| Mar 18, 2025 | 2024 (Q4) | -0.26-0.60 | -0.54 | -11.67% (-0.06) | |
| Nov 06, 2024 | 2024 (Q3) | -0.41-0.41 | -0.54 | 23.33% (+0.13) | |
| Aug 07, 2024 | 2024 (Q2) | -0.62-0.48 | -0.6 | 19.40% (+0.12) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
